Boston Scientific Corporation BSX-PA NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score

76/100

5/7 Pass

SharesGrow Intrinsic Value

Boston Scientific Corporation (BSX-PA) 产生了 $4.53B 经营性现金流財年 2025. 扣除资本支出 $876M, 自由现金流为 $3.66B.

自由现金流利润率为 18.2% 佔营收. 现金转換率为 1.57x, 表明盈利有现金支撐.

本页支持的标准:

HEALTH (83/100, Pass) — 表明公司能够轻鬆償还债务
MOAT (86/100, Pass) — $3.66B (18.2% FCF margin) 支持持久的竞争优势
INCOME (55/100) — 现金转換率为 1.57x 确认盈利有真实现金流支撐

SharesGrow 收入评分: 76/100 其中 5/7 项标准通过.

SharesGrow 7-Criteria Score

76/100

SG Score

View full scorecard →

✗

价值

15/100

Price-to-Earnings & upside

→ Valuation

✓

未來

100/100

Analyst consensus

→ Forecast

✓

过去

100/100

→ Income

✓

健康

83/100

Debt-to-Equity & liquidity

Proven by this page

✓

护城河

86/100

Proven by this page

✓

成长

90/100

→ Income

收入

55/100

→ Income

Boston Scientific Corporation 现金流量历史

指标	TTM	FY2025	FY2024	FY2023	FY2022
Operating Cash Flow	$4.53B	$4.53B	$3.44B	$2.5B	$1.53B
资本支出	$-909M	$-876M	$-790M	$-800M	$-612M
Free Cash Flow	$3.63B	$3.66B	$2.65B	$1.7B	$914M

其他人也在看

Becton, Dickinson and Company

$48.16

+1.39%

CFG-PE

Citizens Financial Group, Inc.

$19.03

+0.32%

DLR-PL

Digital Realty Trust, Inc.

$19.87

+0.65%

LLY

Eli Lilly and Company

Boston Scientific Corporation BSX-PA NYSE

其他人也在看

获取低估股票提醒